CARDIOMYOPATHY, SECONDARY MALIGNANCIES, EXTRAVASATION AND TISSUE NECROSIS, and SEVERE MYELOSUPPRESSION
See full prescribing information for complete boxed warning.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Adiblastine; Adriablastine; Adriacin; Adriamycin (Bedford); Adriblatina; Doxil (Tibotec); Farmablastina; Rubex (Mead Johnson)
- INDICATIONS: Carcinomas, leukemias, sarcomas
- SYNONYM: hydroxydaunomycin
- CLASS: Antibiotic, Antibiotic; anthracycline, Antimicrobial
- HALF-LIFE: 20–48 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aldesleukin, Cabazitaxel, CYP2D6 inhibitors or inducers, CYP3A4 inhibitors or inducers, Gadobenate, P-glycoprotein inhibitors or inducers, Paclitaxel, Sorafenib, Stavudine, Trastuzumab, Zidovudine
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 02/09/2025
